A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2
about
Defining the blanks--pharmacochaperoning of SLC6 transporters and ABC transportersThe impact of human hyperekplexia mutations on glycine receptor structure and functionMolecular basis of the dominant negative effect of a glycine transporter 2 mutation associated with hyperekplexia.Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain.Constitutive endocytosis and turnover of the neuronal glycine transporter GlyT2 is dependent on ubiquitination of a C-terminal lysine clusterPresynaptic control of glycine transporter 2 (GlyT2) by physical and functional association with plasma membrane Ca2+-ATPase (PMCA) and Na+-Ca2+ exchanger (NCX)Calnexin-assisted biogenesis of the neuronal glycine transporter 2 (GlyT2).Novel missense mutations in the glycine receptor β subunit gene (GLRB) in startle diseaseDistinct phenotypes in zebrafish models of human startle disease.A cytosolic relay of heat shock proteins HSP70-1A and HSP90β monitors the folding trajectory of the serotonin transporter.A novel compound mutation in GLRA1 cause hyperekplexia in a Chinese boy- a case report and review of the literature.Relax, Cool Down and Scaffold: How to Restore Surface Expression of Folding-Deficient Mutant GPCRs and SLC6 Transporters.SLC6 Transporter Folding Diseases and Pharmacochaperoning.Glycine Transporters in Glia Cells: Structural Studies.Modification of a Putative Third Sodium Site in the Glycine Transporter GlyT2 Influences the Chloride Dependence of Substrate TransportImpaired Glycine Receptor Trafficking in Neurological Diseases
P2860
Q26825537-45058A1D-2155-4939-AA15-2A8A2F24E81CQ26830661-CB9153A1-EF9A-4A2C-AEF9-7DC7AE8368D2Q30369445-C566244B-43DA-45F3-9F2C-B3A9896FA1F3Q34381226-957F6BF5-7305-4F32-8F0F-C5D9D15E42C8Q34618969-86FE3025-2E3B-4F01-9955-70EC3FE157EEQ34634323-547F03A2-92CC-4E0F-9B21-D1128D4BF70CQ34708538-AE21B166-2731-4418-AEC3-77A0403BC1F9Q36636926-44CDB768-8224-44F9-A69D-576B77949B1AQ37679180-313921CC-AD7C-401C-99E3-7583235206EBQ42272217-62438CED-744D-49AC-B243-7AA357F517B0Q42372226-FD42DC54-4110-41FB-9FE9-5B3A21B18F67Q47141268-FDA79C45-C0BB-4D92-82B3-AC865F89829EQ47585152-53F646CC-B259-46D1-B59D-558A3D986244Q47923197-FF3389A1-41E9-44BF-9CD4-AC2AD6A171C5Q57492430-9BF1FEDB-DD6F-4FD3-B909-AA5A5A0DF36AQ58728657-74EC6221-35AD-4141-AAEE-6AA2CAF51276
P2860
A novel dominant hyperekplexia mutation Y705C alters trafficking and biochemical properties of the presynaptic glycine transporter GlyT2
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@ast
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@en
type
label
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@ast
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@en
prefLabel
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@ast
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@en
P2093
P2860
P50
P356
P1476
A novel dominant hyperekplexia ...... ptic glycine transporter GlyT2
@en
P2093
Carmen Aragón
Enrique Fernández-Sánchez
Enrique Núñez
Esperanza Jiménez
Gonzalo Pérez-Siles
Ignacio Ibáñez
Jaime Martínez-Villarreal
Jaime de Juan-Sanz
Julián Nevado
Lourdes R Desviat
P2860
P304
28986-29002
P356
10.1074/JBC.M111.319244
P407
P50
P577
2012-06-29T00:00:00Z